| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |